You are here

AusPAR: Upadacitinib

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

12 May 2020
AusPAR Details
AusPAR
Active Ingredient
Upadacitinib
Product Name
Rinvoq
Sponsor
AbbVie Pty Ltd
Submission Number
PM-2018-05603-1-3
Submission Type
New chemical entity
Decision
Approved
AusPAR Date
24 April 2020
Publication Date

12 May 2020